APN-007
Summary This application note explains how Gelomics Cloud connects well-level experiment design, LunaX™ device operation and structured documentation. Direct Cloud-to-device syncing removes manual re-entry, while reusable designs, protocol exports and…
APN-006
Summary This application note demonstrates rapid recovery of viable MDA-MB-231 breast cancer cells from 2, 4 and 6 kPa LunaX™ ECMs. The LunaX Cell Recovery Kit fully digested each matrix…
APN-005
Summary This application note demonstrates how ECM stiffness regulates hepatic iron biology in C3A liver spheroids. Compared with 2D culture and Matrigel®, LunaX™ ECM supported more uniform spheroids and stiffness-dependent…
APN-004
Summary This application note shows how a defined 5 kPa LunaX™ ECM model detects IGF-I:IGFBP-3:vitronectin-driven growth in SK-MEL-28 melanoma spheroids. LunaX produced a clear dose-dependent response over 14 days and…
APN-003
Summary This application note demonstrates how LunaX™ ECM reveals breast cancer subtype-specific responses to Abraxane that conventional 2D assays miss. In 3D culture, compact MCF-7 spheroids showed greater resistance, while…
APN-002
Summary This application note shows how tunable LunaX™ ECM was used to engineer humanised prostate tumour, bone, bone marrow and adipose niches. Across three peer-reviewed studies, these models captured species-specific…
APN-001
Summary This application note demonstrates how LunaX™ ECM, tuned to a physiologically relevant stiffness of 1.5 kPa, supports the development of stable capillary-like networks in HUVEC–pericyte co-cultures. Over seven days,…
